Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Rheum After 5: Dr. Elizabeth Hazel, Olympian

Carol Patton  |  November 11, 2024

Dr. Elizabeth Hazel reflects on her experience as a Canadian swimming competitor in the 1992 Summer Olympics.

Filed under:ProfilesRheum After 5 Tagged with:Dr. Elizabeth Hazel

Lupus & Nightmares

Lara C. Pullen, PhD  |  November 11, 2024

Dr. David D’Cruz’s research attempts to help patients make sense of chronic nightmares, an understudied symptom of lupus.

Filed under:ConditionsPatient PerspectiveSystemic Lupus Erythematosus Tagged with:Neurologyneuropsychiatricneuropsychiatric lupusSLE Resource Centersuicide

Can Primary Care Physicians Help Rheumatology’s Workforce Shortages?

Ruth Jessen Hickman, MD  |  November 11, 2024

In an effort to ameliorate serious rheumatology provider shortages, the ACR Workforce Solutions Committee has developed a new resource for primary care providers who treat patients with rheumatic conditions.

Filed under:Practice SupportWorkforce Tagged with:Primary Care Physicians

AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM

By Matthew A. Sherman, MD, MHSc, & Stacey E. Tarvin, MD, MS  |  November 10, 2024

Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesMyositisResearch Rheum Tagged with:juvenile dermatomyositisReading Rheum

Insight into the ACR’s Commitment to an Inclusive Committee Composition

Kanika Monga, MD, FACR  |  October 9, 2024

“While our group carefully considered your application, I regret to inform you that you were not selected this year to serve as a committee volunteer.” When the email arrived, gently delivering the news that my application to volunteer with the ACR on a committee had not been accepted, my initial reaction was to dismiss it…

Filed under:From the College Tagged with:ACR standing committeesDiversity

Case Report: Voriconazole-Induced Periostitis

Amanda Moyer, MD, & Tamiko Katsumoto, MD  |  October 8, 2024

In this case report, a patient with voriconazole-induced periostitis exhibits classic symptoms & elevated ALP levels, which quickly resolve following the discontinuation of voriconazole.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone paincase reportskeletal fluorosisvoriconazolevoriconazole-induced periostitis

My Rheumatology Research Workshop 2024 Experience

Ioannis Koulas, MD, MS  |  October 7, 2024

The 2024 Rheumatology Research Workshop facilitated educational and relationship-building experiences for early-career and established rheumatology professionals alike. 

Filed under:CareerCareer DevelopmentMeeting Reports Tagged with:ACR Rheumatology Research WorkshopRheumatology Research FoundationRheumatology Research Workshop

Meet the 2024 Lupus Insight Prize Honorees

Gretchen Henkel  |  October 7, 2024

Marko Radic, PhD, & Georg Schett, MD, were awarded the 2024 Lupus Insight Prize for advances in CAR-T cell therapy. 

Filed under:AwardsConditionsSystemic Lupus Erythematosus Tagged with:Dr. Georg SchettDr. Marko Z. RadicLupus Insight PrizeLupus Research AllianceSLE Resource Center

With an Aging State Population, California Rheumatology Association Prepares to Increase Its Rheumatology Workforce

Linda Childers  |  October 6, 2024

The organization is supporting multiple bills and initiatives to protect and expand rheumatology care in the state.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:California Rheumatology Alliancestate society

How to Manage Lupus Nephritis: A New Guideline Introduced

Keri Losavio  |  September 26, 2024

A new guideline, the 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis, is being introduced at ACR Convergence 2024 on Monday, Nov. 18. In the session, Lisa Sammaritano, MD, professor of clinical medicine at Weill Cornell Medicine and Hospital for Special Surgery, New York, will discuss the guideline development process and…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024ACR Convergence 2024 SLE

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences